The role of insulin sensitising agents in polycystic ovary syndrome

Harborne, Lyndal Ruth (2005) The role of insulin sensitising agents in polycystic ovary syndrome. MD thesis, University of Glasgow.

Abstract

Polycystic Ovary Syndrome (PCOS) is a common disorder of chronically abnormal ovarian function and hyperandrogenism whose clinical effects include oligomenorrhoea and hirsutism. It has been determined that the principal underlying defect is hyperinsulinaemia secondary to insulin resistance. Use of insulin sensitising agents in women with PCOS is becoming increasingly widespread. Trials with metformin, one such agent, enthusiastically report a wide range of benefits in metabolic, reproductive and clinical measures. We have shown that metformin treatment of women with polycystic ovary syndrome has the following effects; o It may be more effective than Dianette in the treatment of hirsutism. o It is effective in reducing weight and improves lipid profiles in obese women with oligomenorrhea or a raised free androgen index. o It reduces serum mullerian inhibiting substance in the circulation after protracted treatment (> 4months). o It has effects upon adrenal androgen biosynthesis manifested by a reduction in circulating basal concentrations of 170HP.

• Item Type: Thesis (MD)
• Qualification Level: Doctoral
• Keywords: Immunology.
• Colleges/Schools: College of Medical Veterinary and Life Sciences
• Supervisor's Name: Norman, Dr. Jane
• Date of Award: 2005
• Depositing User: Enlighten Team
• Unique ID: glathesis:2005-71489
• Copyright: Copyright of this thesis is held by the author.
• Date Deposited: 17 May 2019 09:31
• Last Modified: 16 Aug 2021 14:49
• URI: https://theses.gla.ac.uk/id/eprint/71489

Related URLs

• Article DOI
• Article DOI
• Article DOI
• Article DOI